As the weather warms up, so do innovations in the world of pharma! This issue covers the latest pharma news, from the US FDA granting Investigational New Drug clearance to Spero Therapeutics’ bacterial infection treatment (
page 5), and Merck sharing data from its phase 3 trial of Keytruda as a treatment for cervical cancer (
page 6), to Novo Nordisk’s Awiqli being recommended by the Committee for Medicinal Products for Human Use for diabetes treatment (
page 9) and finally Fusion Therapeutics’ acquisition by AstraZeneca (
page 12).